Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer work Gallery Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer work All News, Portfolio News Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer workartrix2021-02-08T23:06:15-08:00February 5th, 2021|Read More
Vivo Capital and an Investor Syndicate Completes Sale of Surgical Specialties Corporation to GTCR-backed Corza Health Gallery Vivo Capital and an Investor Syndicate Completes Sale of Surgical Specialties Corporation to GTCR-backed Corza Health All News, Portfolio News Vivo Capital and an Investor Syndicate Completes Sale of Surgical Specialties Corporation to GTCR-backed Corza Healthartrix2021-02-08T23:04:27-08:00February 1st, 2021|Read More
Congratulations to Prof. Frances Arnold, the first American woman to win the Nobel Prize in Chemistry and co-founder of Vivo portfolio company Provivi, for her recent appoint as Co-Chair of President-elect Biden’s Council of Advisors on Science and Technology (PCAST)! Gallery Congratulations to Prof. Frances Arnold, the first American woman to win the Nobel Prize in Chemistry and co-founder of Vivo portfolio company Provivi, for her recent appoint as Co-Chair of President-elect Biden’s Council of Advisors on Science and Technology (PCAST)! All News, Portfolio News Congratulations to Prof. Frances Arnold, the first American woman to win the Nobel Prize in Chemistry and co-founder of Vivo portfolio company Provivi, for her recent appoint as Co-Chair of President-elect Biden’s Council of Advisors on Science and Technology (PCAST)!artrix2021-01-18T20:57:50-08:00January 15th, 2021|Read More
Vivo Portfolio Company, Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater China Gallery Vivo Portfolio Company, Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater China All News, Portfolio News Vivo Portfolio Company, Aadi Bioscience and EOC Pharma Announce License and Collaboration Agreement for ABI-009 (FYARROTM) in Greater Chinaartrix2021-01-14T20:40:39-08:00January 11th, 2021|Read More
Verona Pharma Raises $200Million in Oversubscribed Private Placement and Subscription Gallery Verona Pharma Raises $200Million in Oversubscribed Private Placement and Subscription All News, Portfolio News Verona Pharma Raises $200Million in Oversubscribed Private Placement and Subscriptionartrix2020-11-01T16:37:55-08:00September 17th, 2020|Read More
PatientPop Announces $50M in Series C Funding Gallery PatientPop Announces $50M in Series C Funding All News, Portfolio News PatientPop Announces $50M in Series C Fundingartrix2020-11-01T16:34:46-08:00August 25th, 2020|Read More
ALX Oncology Announces Pricing of Initial Public Offering Gallery ALX Oncology Announces Pricing of Initial Public Offering All News, Portfolio News ALX Oncology Announces Pricing of Initial Public Offeringartrix2020-07-25T10:49:23-07:00July 16th, 2020|Read More
Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital Gallery Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capital All News, Portfolio News Preventice Solutions Announces $137 Million Series B Financing Led by Vivo Capitalartrix2020-07-16T22:33:36-07:00July 15th, 2020|Read More
Genetron Health Announces Pricing of Initial Public Offering Gallery Genetron Health Announces Pricing of Initial Public Offering All News, Portfolio News Genetron Health Announces Pricing of Initial Public Offeringartrix2020-06-20T10:42:44-07:00June 19th, 2020|Read More
IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants Gallery IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants All News, Portfolio News IVERIC bio, Inc. Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrantsartrix2020-06-20T10:44:04-07:00June 18th, 2020|Read More
Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 Gallery Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 All News, Portfolio News Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19artrix2020-06-18T16:56:31-07:00June 13th, 2020|Read More
Legend Biotech Corporation Announces Pricing of Initial Public Offering Gallery Legend Biotech Corporation Announces Pricing of Initial Public Offering All News, Portfolio News Legend Biotech Corporation Announces Pricing of Initial Public Offeringartrix2020-06-18T16:55:24-07:00June 5th, 2020|Read More
Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform Gallery Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform All News, Portfolio News, Vivo News Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platformartrix2020-04-21T13:06:00-07:00April 21st, 2020|Read More
RemeGen Completes USD $100 Million Plus in Funding Gallery RemeGen Completes USD $100 Million Plus in Funding All News, Portfolio News RemeGen Completes USD $100 Million Plus in Fundingartrix2020-04-21T13:04:42-07:00April 2nd, 2020|Read More
Gilead to Acquire Forty Seven for $4.9 Billion Gallery Gilead to Acquire Forty Seven for $4.9 Billion All News, Portfolio News Gilead to Acquire Forty Seven for $4.9 Billionartrix2020-06-18T17:04:46-07:00March 2nd, 2020|Read More
Passage Bio Announces Pricing of Initial Public Offering Gallery Passage Bio Announces Pricing of Initial Public Offering All News, Portfolio News Passage Bio Announces Pricing of Initial Public Offeringartrix2020-06-18T17:01:08-07:00February 27th, 2020|Read More
Revolution Medicines Announces Pricing of Initial Public Offering Gallery Revolution Medicines Announces Pricing of Initial Public Offering All News, Portfolio News Revolution Medicines Announces Pricing of Initial Public Offeringartrix2020-06-18T17:03:04-07:00February 12th, 2020|Read More
Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors Gallery Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumors All News, Portfolio News Bolt Bio preps clinical trials of immune-stimulating cancer drug in stubborn solid tumorsartrix2019-11-13T04:26:51-08:00November 11th, 2019|Read More
Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants Gallery Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants All News, Portfolio News Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrantsartrix2020-06-20T10:45:51-07:00November 7th, 2019|Read More
IGM Biosciences Announces Pricing of Initial Public Offering Gallery IGM Biosciences Announces Pricing of Initial Public Offering All News, Portfolio News IGM Biosciences Announces Pricing of Initial Public Offeringartrix2020-06-18T16:58:47-07:00September 17th, 2019|Read More
AtriCure Enters Into Definitive Agreement to Acquire SentreHEART Gallery AtriCure Enters Into Definitive Agreement to Acquire SentreHEART All News, Portfolio News AtriCure Enters Into Definitive Agreement to Acquire SentreHEARTartrix2019-10-19T05:30:49-07:00August 12th, 2019|Read More
Vivo Capital to Sponsor New Frontier Corporation’s Acquisition of United Family Healthcare Gallery Vivo Capital to Sponsor New Frontier Corporation’s Acquisition of United Family Healthcare All News, Portfolio News, Vivo News Vivo Capital to Sponsor New Frontier Corporation’s Acquisition of United Family Healthcareartrix2020-01-22T00:29:14-08:00July 30th, 2019|Read More
MacuLogix® Raises $38.7 Million in Series D Financing Led by Vivo Capital Gallery MacuLogix® Raises $38.7 Million in Series D Financing Led by Vivo Capital All News, Portfolio News MacuLogix® Raises $38.7 Million in Series D Financing Led by Vivo Capitalartrix2020-11-01T16:31:29-08:00March 4th, 2019|Read More
Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis Gallery Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis All News, Portfolio News Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasisartrix2019-10-19T05:31:06-07:00December 10th, 2018|Read More
Impel NeuroPharma Closes $67.5 Million Series D Financing Gallery Impel NeuroPharma Closes $67.5 Million Series D Financing All News, Portfolio News, Vivo News Impel NeuroPharma Closes $67.5 Million Series D Financingartrix2019-10-19T05:34:48-07:00December 6th, 2018|Read More
Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine Gallery Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraine All News, Portfolio News Biohaven Delivers Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Migraineartrix2019-10-19T05:31:30-07:00December 3rd, 2018|Read More
Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China Gallery Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China All News, Portfolio News, Vivo News Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in Chinaartrix2019-10-19T05:35:03-07:00November 8th, 2018|Read More
Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer Gallery Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer All News, Portfolio News, Vivo News Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancerartrix2019-10-19T05:35:16-07:00October 30th, 2018|Read More
Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering Gallery Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering All News, Portfolio News Crinetics Pharmaceuticals Announces Pricing of Initial Public Offeringartrix2019-10-19T05:32:01-07:00July 17th, 2018|Read More
Sinovac Raises $86.73 Million Through Private Placement Transaction Gallery Sinovac Raises $86.73 Million Through Private Placement Transaction All News, Portfolio News, Vivo News Sinovac Raises $86.73 Million Through Private Placement Transactionartrix2019-10-19T05:35:28-07:00July 3rd, 2018|Read More
Tricida Announces Pricing of Initial Public Offering Gallery Tricida Announces Pricing of Initial Public Offering All News, Portfolio News Tricida Announces Pricing of Initial Public Offeringartrix2019-10-19T05:32:18-07:00June 27th, 2018|Read More